Dr. Kevin Patrick Boyd, MD

Dr. Boyd practices at Mayo Clinic Health System Mankato Hospital in Mankato, Minnesota.

Dr. Boyd's NPI, 1215162417, was assigned on May 18, 2009. Dr. Boyd holds Wisconsin license 77791.

Dr. Boyd's primary practice is Mayo Clinic Health System Mankato Hospital, at 1025 Marsh St, Mankato, MN 56001 in Blue Earth County. The practice phone is (507) 594-6449.

Dr. Boyd's primary practice is Mayo Clinic Health System Mankato Hospital in Mankato, Minnesota. Dr. Boyd is also affiliated with Mayo Clinic Health System in Mankato. The medical group on file is Mayo Clinic Health System in Mankato. Dmand AI also links Dr. Boyd to 4 more hospitals, 2 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boyd practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Boyd's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Boyd's licenses on file in 4 states: Wisconsin, Alabama, Colorado and Minnesota.

CMS data shows 4,142 Medicare services from Dr. Boyd across 6 procedure codes in 2024, for 2,041 Medicare patients. Medicare paid $105,006 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 2,041 Medicare patients who saw Dr. Boyd in 2024. The largest group is 65 to 74, with 867 patients. 71% of them have high cholesterol, and 69% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boyd's median patient age at 73, with 48% women.

In 2024, Dr. Boyd wrote 30 Medicare Part D claims for 12 patients. 97% of them were for generic drugs. They cover 2 drugs, with $772 in total drug cost. In 2019, CMS named 45 claims across 3 drugs.

Dr. Boyd accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 35 general payments to Dr. Boyd from 8 drug and device companies from 2017 to 2018. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $286.